Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist gegebenenfalls nur via VPN oder Shibboleth (DFN-AAI) möglich. mehr Informationen...
Sortiert nach
Einfacher Volltextzugriff von (fast) überall
Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...
Open Access
    Datensatz exportieren als...
  • BibTeX
The PI3K/AKT/mTOR pathway in breast cancer: targets, trials and biomarkers
Therapeutic Advances in Medical Oncology, 2014-07, Vol.6 (4), p.154-166
2014
Volltextzugriff (PDF)
Open Access
    Datensatz exportieren als...
  • BibTeX
Impact of tamoxifen therapy on fertility in breast cancer survivors
Fertility and sterility, 2017-01, Vol.107 (1), p.243-252.e5
2017
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
ABP 980: promising trastuzumab biosimilar for HER2-positive breast cancer
Expert opinion on biological therapy, 2018-03, Vol.18 (3), p.335-341
2018
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
Everolimus: side effect profile and management of toxicities in breast cancer
Breast cancer research and treatment, 2013-08, Vol.140 (3), p.453-462
2013
Volltextzugriff (PDF)
Open Access
    Datensatz exportieren als...
  • BibTeX
Signet ring cell carcinoma of the ampulla of Vater with leptomeningeal metastases: a case report
Journal of clinical oncology, 2011-07, Vol.29 (21), p.e627-e629
2011
Volltextzugriff (PDF)
Open Access
    Datensatz exportieren als...
  • BibTeX
Tucatinib vs Placebo, Both in Combination With Trastuzumab and Capecitabine, for Previously Treated ERBB2 (HER2)-Positive Metastatic Breast Cancer in Patients With Brain Metastases: Updated Exploratory Analysis of the HER2CLIMB Randomized Clinical Trial
JAMA oncology, 2023-02, Vol.9 (2), p.197
2023
Volltextzugriff (PDF)
Open Access
    Datensatz exportieren als...
  • BibTeX
Association of Circulating Tumor DNA and Circulating Tumor Cells After Neoadjuvant Chemotherapy With Disease Recurrence in Patients With Triple-Negative Breast Cancer: Preplanned Secondary Analysis of the BRE12-158 Randomized Clinical Trial
JAMA oncology, 2020-09, Vol.6 (9), p.1410
2020
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
Abstract OT2-16-01: The SMILE study: A phase 2 trial of onapristone in combination with fulvestrant for patients with ER+ and HER2- metastatic breast cancer after progression on endocrine therapy and CDK4/6 inhibitors
Cancer research (Chicago, Ill.), 2022-02, Vol.82 (4_Supplement), p.OT2-16-01-OT2-16-01
2022
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
Predictors of Survival after Yttrium-90 Radioembolization of Chemotherapy-Refractory Hepatic Metastases from Breast Cancer
Journal of vascular and interventional radiology, 2020-06, Vol.31 (6), p.925-933
2020
Volltextzugriff (PDF)
Open Access
    Datensatz exportieren als...
  • BibTeX
P38 MAPK contributes to resistance and invasiveness of HER2- overexpressing breast cancer
Current medicinal chemistry, 2014-02, Vol.21 (4), p.501-510
2014
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
BRE12-158: A Postneoadjuvant, Randomized Phase II Trial of Personalized Therapy Versus Treatment of Physician's Choice for Patients With Residual Triple-Negative Breast Cancer
Journal of clinical oncology, 2022-02, Vol.40 (4), p.345-355
2022
Volltextzugriff (PDF)
Open Access
    Datensatz exportieren als...
  • BibTeX
Preservation of quality of life in patients with human epidermal growth factor receptor 2–positive metastatic breast cancer treated with tucatinib or placebo when added to trastuzumab and capecitabine (HER2CLIMB trial)
European journal of cancer (1990), 2021-08, Vol.153, p.223-233
2021
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
Abstract PD4-04: Updated results of tucatinib vs placebo added to trastuzumab and capecitabine for patients with previously treated HER2-positive metastatic breast cancer with brain metastases (HER2CLIMB)
Cancer research (Chicago, Ill.), 2022-02, Vol.82 (4_Supplement), p.PD4-04-PD4-04
2022
Volltextzugriff (PDF)
Open Access
    Datensatz exportieren als...
  • BibTeX
Cancer Treatment-Related Cardiovascular Toxicity in Gynecologic Malignancies
JACC CardioOncology, 2023-04, Vol.5 (2), p.159-173
2023
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
Updated results of tucatinib versus placebo added to trastuzumab and capecitabine for patients with pretreated HER2+ metastatic breast cancer with and without brain metastases (HER2CLIMB)
Journal of clinical oncology, 2021-05, Vol.39 (15_suppl), p.1043-1043
2021
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
Abstract PD9-10: BRE12-158: A post-neoadjuvant, randomized phase 2 trial of personalized therapy vs. treatment of physician’s choice for patients with residual triple negative breast cancer
Cancer research (Chicago, Ill.), 2022-02, Vol.82 (4_Supplement), p.PD9-10-PD9-10
2022
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
Abstract PD13-04: Impact of tucatinib on health-related quality of life in patients with HER2+ metastatic breast cancer with stable and active brain metastases
Cancer research (Chicago, Ill.), 2021-02, Vol.81 (4_Supplement), p.PD13-04-PD13-04
2021
Volltextzugriff (PDF)
Open Access
    Datensatz exportieren als...
  • BibTeX
Insulin-like growth factor-1 receptor signaling increases the invasive potential of human epidermal growth factor receptor 2-overexpressing breast cancer cells via Src-focal adhesion kinase and forkhead box protein M1
Molecular pharmacology, 2015-02, Vol.87 (2), p.150-161
2015
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
Management of adverse events in patients with HER2+ metastatic breast cancer treated with tucatinib, trastuzumab, and capecitabine (HER2CLIMB)
Journal of clinical oncology, 2020-05, Vol.38 (15_suppl), p.1043-1043
2020
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
Abstract GS5-02: Detection of circulating tumor DNA (ctDNA) after neoadjuvant chemotherapy is significantly associated with disease recurrence in early-stage triple-negative breast cancer (TNBC): Preplanned correlative results from clinical trial BRE12-158
Cancer research (Chicago, Ill.), 2020-02, Vol.80 (4_Supplement), p.GS5-02-GS5-02
2020
Volltextzugriff (PDF)
Open Access
    Datensatz exportieren als...
  • BibTeX
Tucatinib, Trastuzumab, and Capecitabine for HER2-Positive Metastatic Breast Cancer
The New England journal of medicine, 2020-02, Vol.382 (6), p.586-586
2020
Volltextzugriff (PDF)
Open Access
    Datensatz exportieren als...
  • BibTeX
Cancer Treatment-Related Cardiovascular Toxicity in Gynecologic Malignancies: State-of-the-Art Review
JACC CardioOncology, 2023-04, Vol.5 (2), p.159-173
2023
Volltextzugriff (PDF)
Open Access
    Datensatz exportieren als...
  • BibTeX
New and emerging treatments for estrogen receptor-positive breast cancer: focus on everolimus
Therapeutics and clinical risk management, 2013-01, Vol.9 (default), p.27-36
2013
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
Abstract GS1-01: Tucatinib vs placebo, both combined with capecitabine and trastuzumab, for patients with pretreated HER2-positive metastatic breast cancer with and without brain metastases (HER2CLIMB)
Cancer research (Chicago, Ill.), 2020-02, Vol.80 (4_Supplement), p.GS1-01-GS1-01
2020
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
Cancer Treatment-Related Cardiovascular Toxicity in Gynecologic Malignancies: JACC: CardioOncology State-of-the-Art Review
JACC CardioOncology, 2023-04, Vol.5 (2), p.159-173
2023
Volltextzugriff (PDF)
1 – 25 von 31
Suche als RSS-Feed
Aktive Filter
ThemaAntineoplastic Combined Chemotherapy Protocols - Therapeutic Use
Nur zeigenGeprüft (Peer-Review)
Suchergebnisse filtern
Filter anzeigen